BRIEF-Oxford Biomedica says GSK options rare disease candidates

Wed Dec 18, 2013 2:29am EST

Related Topics

Dec 18 (Reuters) - Oxford BioMedica PLC : * Announces option agreement with GlaxoSmithkline * Grants GSK an option for the development of up to six candidates targeting

rare orphan diseases * Source text

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.